chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Shortly after receiving the vaccine, client began to vomit.  Blood pressure is normally low, but hard to auscultate, hear.  Client is alert and oriented x3, pulse 89-99, 100% oxygen saturation, bp=90/50.  After water and snacks, was able to discharge from the recovery area at 1520.
SORE THROAT, LOW GRADE FEVER, HEADACHE, NAUSEA, NASAL SECRETIONS, COUGH, SLEEPINESS TOOK NYQUIL FOR 3 DAYS
On Monday, 3 days after the 1st shot, I experienced the onset of a shingles like feeling in a typical outbreak site. It never developed a prodrone but I experienced the feelings right before an outbreak. NO fever, or body aches at all.
some mild swelling , erythema no pain in area of injection; some mild swelling , erythema no pain in area of injection; This is a spontaneous report from a contactable physician.   A female patient of an unspecified age received meningococcal group b rlp2086 (TRUMENBA), via an unspecified route of administration at single dose on 17Dec2019 10:42 for immunisation.  Medical history included rheumatoid arthritis. Concomitant medications were not reported. The patient previously took meningococcal group b rlp2086 for immunisation on 24Oct2019 and experienced mild swelling, erythema and pain in area of injection.  On 18Dec2019 15:00, the patient experienced some mild swelling , erythema no pain in area of injection. She denied any fever or systemic signs. No medication taken. The outcome of the events was recovered on 22Dec2019 at 08:00.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
06//03 NIGHT--FEVER-CHILLS-MUSCLE JOINTS ACHING-HEADEACE-TX ALTERNATING TYLENOL AND MOTRIN 06/04 DAY--NO APPEITE MUSCLE ACHES-FATIGUE-TYLENOL WITH MOTRHIN WHEN NEEDED 06/05--STILL NO APPETITE-SOME NAUSEA WITH EATING -NO ENERGY-FATIGUE                  FELT SL BETTER AT NIGHT WITH JUST LEGS ACHING-TYLENOL BEFORE BEDSTIME. 06/06 EARLY AM WOKE WITH BOTH ARMS ACHING-TOO MORE TYLENOL USUALLY PLAY PICKLE BALL BUT THIS AM ARMS FELTS HEAVY AND ACHING-TOOK MORE TYLENOL
No Initial reaction, after 30 minutes one ear turned red and hot, bottom lip and right side of face began to swell. Heart rate elevated to sustained 120s. Benadryl dose taken with pepcid and nurse monitored symptoms for 20 mins. Symptoms subsided. 4 hrs later, lip swelling began again but both lips this time, face also started to swell, hives developed on neck and chest, tongue began to swell and heart rate rose to 150s sustained. Intense dizziness and shortness of breath began as well. More Benadryl and pepcid we're taken, no results. Visited an ER but after an EKG, was made to wait for 3hrs so I left and went home with my epiPen because my heart rate had started to come down. I began to itch uncontrollably and realized the hives had spread over most of my body. Atarax taken and multiple episodes of elevated heart rate woke me up with heavy sweating overnight. Woke up to swollen eye lids, lips and face but no more hives. More Benadryl taken with some improvement. Midday ate a small lunch or a vegan protein sandwich and lips began to swell again. Took more Benadryl and pepcid and rushed to my PCP who administered an IM steroid shot and prescribed oral steroids and atarax until all symptoms are gone.
This spontaneous report as received from a physician via a company representative refers to unspecified number of patients of unknown age. On unknown dates, the patients were vaccinated with ZOSTAVAX (dose, route and lot number not reported). It was reported that an unspecified number of patients developed shingles after receiving ZOSTAVAX. The outcome of the adverse events was unknown. Additional information is not expected.
Early October my husband had symptoms and tests before me and I thought I was having my normal allergy stuff going on and when it persisted a few days I went and got a test myself and I tested positive. I had a considerably bad headache and my migraine medication wasn't working but it was instantly gone after I got the monoclonal antibody infusion. All my symptoms were gone after the infusion except the smell and taste which is still happening and not back yet. I had positive test for Covid and 2 days later I had the infusion.
Patient mother states that on October 20th patient had a twitch (tic) while at school which made her throw down an item she had in her hands. The tics have continued randomly. The twitch involves her arm, torso and neck. Has received flu vaccinations previously. Went to pediatrician and they referred the patient to neurologist (appointment not scheduled yet) and to have pharmacy report to VAERs.
Immediately felt ?funny? but nothing of alarm.  Went home and about 2 hours later still felt different. I was resting on the couch in preparation for any side effect such as flu like feelings.  2 hours after shot, I noticed my heartbeat rising.  I wear an iwatch and I monitored my heart rate.  I was resting, not moving and I watched the beats per min go from 80s, and rise all the way to 165. Within minutes.  I passed out for a quick second before calling my husband for help. I had trouble breathing. My face and lips felt tingly.  My heart was out of control beating so fast and I was scared.  I am 35 and work out high intensity at least 2x a week with no prior conditions.  When I work out my highest bpm is around 150/160. My resting rate is low 70s. My sleep rate is 50s. I have all this data tracked and logged bc of my watch.  On the day of the second dose, it spiked to 165 while in rest and later in the 120s.   My resting heart rate increased to the 80s. And my sleep rate is now in 70s. I am concerned.
Abdominal pain started 3 days after vaccine . Wheezing started approximately 10  minutes after receiving vaccine.   Wheezing resolved before leaving observation area. She was kept in observation area for 30 minutes. Went to Ed for abdominal pain. Has history of post surgical nerve pain.  Consulted her MD who felt the vaccine may have aggravated the previous scar tissue, pain issues. CAT scans have been clear. Lost control of right leg 3 days after vaccine. Was seen in ED RPH.  She was directed her second Pfizer vaccine needs to be given in a more controlled medical environment.
Developed symptoms of severe headache, fatigue, dizziness, abnormal vision and excessive sleeping on about 5/2/2007, 5 weeks after receiving HPV #1 and about 1 week after diagnosis of acute Group A strep throat on 4/26/2007.  She continued to have prolonged symptoms and MRI of brain was performed on 5/23/07 and was consistent with Acute disseminating encephalomyelitis.  She was hospitalized for several days and treated with IV steroids and bed rest.  She had a prolonged convalescence but for the most part all symptoms had completely resolved by August 2007 except for continued headaches for which she takes amytriptline rather regularly.  She continues to have psychologic issues, but these pre-dated HPV vaccine and I do not think they are the result of HPV.  She sees a psychologist regularly.  She has not received any further HPV due to concern about possible connection with her A.D.E.M. 2/24/09-records received for DOS 5/30-6/2/07-DC DX:post lumbar puncture headache. Acute disseminated encephalomyelitis (ADEM). One month prior received treatment for infectious cerebellitis and a diagnosis of ADEM 2-3 weeks prior to admission. Prior to lumbar puncture C/O confusion and disorientation. Presented with vomiting and headache. Lower back pain. Blood patch performed. Eye consult 5/23/07-C/O sudden onset horizontal diplopia, dizziness and movement of the environment. 3/23/09-additional information recieved-presented on 5/30/07- with C/O headaches after lumbar puncture. 2-3 weeks ago developed diplopia and a gait imbalance,
Information was received from a health professional concerning an approximately 35 year old female employee who was vaccinated with MMR.  It was reported that the patient failed to seroconvert for measles after 2 series of vaccinations.  It was also noted that the patient stated that the vaccination hurt.  Unspecified medical attention was sought.  No product quality complaint was involved.  Additional information was requested. Follow-up information fromt he nurse confirmed that thepatient "has had 3 MMR vaccinations and still had not converted/showed immunity. Additional infromation is not expected.
Information has been received from a health care worker reporting on behalf of the physician concerning an 85 year old male patient with diet controlled diabetes who on 11/24/03 was vaccinated with a first dose of pneumococcal 23v polysaccharide vaccine (lot # 644218/1027M). Concomitant therapy included an unspecified diabetes medication. The health care worker reported that within two days of the vaccine administration, on 11/26/03, the patient was admitted to the hospital and he was hospitalized for two days, for a range of different problems. The healthcare worker reported the office has not yet received the discharge summary from the hospital and there was no diagnosis in the patient's chart as to what the range of problems were. It was noted the physician hospitalized the patient due to his age. The patient has since recovered. The health care worker wanted to know if there have been any reports of problems with this specific lot of pneumococcal 23v polysaccharide vaccine; however, there was no product quality complaint reported. No additional information was provided. Additional information has been requested. The health care worker also reported another patient who had an experience following vaccination with pneumococcal 23v polysaccharide vaccine. The records of testing prior to release of this lot have been checked by Quality Assurance and found to be satisfactory. The lot complies with the standards of the Center for Biologics Evaluation and Research and was released. Follow up information from the physician reported the patient was vaccinated in the deltoid with a dose of pneumococcal 23v polysaccharide vaccine (lot # 644220/1119M) and not the previously lot number. The physician also reported the number of previous doses as unknown and not the first dose as was previously reported. Additional information is not expected.  The health care worker also reported another pt who had an experience following vaccination with pneumococcal 23v polysaccharide vaccine (WAES#0312USA0539).
fever, chills, myalgia, irresistible cough (dry cough) for 5 days now. rash below the injection site, painful skin to touch
Patient was given diluent of ROTARIX without adding the actual powder. Noticed 2+ days after administration. Mother was informed, plans on coming in to have it readministered.
shingles; other zoster-related injuries; Information has been received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 01-OCT-2016, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, and route not specified) by a health provider for the long-term prevention of shingles and zoster-related conditions. Subsequently (date unknown), the patient was treated by a physician at a medical center for the following injuries resulting from zoster vaccine live (ZOSTAVAX): shingles and other zoster-related injuries (ill-defined disorder). The outcome of the events was unknown.
Developed a large (3 inch diameter) and VERY tender lump in my right arm pit - the arm in which I received the vaccine.
Small rash spots started to form on her legs and now are almost completely covering her legs and are spreading to her tummy, arms, and face. It is a very rough and red rash
Diarrhea; Patient received 1st dose on 02Feb2021, and received second dose on 12Feb2021; Patient received 1st dose on 02Feb2021, and received second dose on 12Feb2021; This is a spontaneous report from a contactable consumer (Patient) or other non health care professional. A 84-years-old non pregnant female patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, solution for injection, Lot number was not reported), dose 2 via an unspecified route of administration, administered in Arm Left on 12Feb2021 at 10:15 (at a age of 84-year-old) as dose 2 single for covid-19 immunisation. Patient received 1st dose BNT162B2 on 02Feb2021 at 12 in right arm with lot number EC-3249 for covid-19 immunization. Patient did not received other vaccines in four weeks. Patient did not had COVID prior vaccination. Patient did not tested COVID post vaccination. The patient medical history was not reported. Patient was not aware of allergies. Concomitant medications included Losartan, Pravastatin and Multivitamin. The patient experienced diarrhea on 13Feb2021 at 02:00 AM. Patient received treatment with dicyclomine. The outcome of event was not recovered. Outcoem of other events were unknown.   No follow-up attempts are possible, information about lot/batch number cannot been obtained.
17MAR97 pt exp ear infect;18MAR97 pt devel red, papular rash, cold-like sx, low grade fever & itchiness;mild case of chickenpox;dx w/viral erythema;pt devel chicken pox w/a fever & pustules all over face & body;
2/05 fever,chills, body aches x 1day-no treatment 2/06 fell getting out of bed(off balance) no treatment Since shot noticed daily body aches in neck ,back.  Short of air with exertion, fatigue.   Week of 2/22 face and hands swelling 02/23 memory lapse at work 2/28 during yard work passed-out followed by fatigue 03/01 found unconscious for several hours, still in the hospital today.
Today I noticed that I have a blotchy area on my left upper arm around the area I received the shot. It is warm to the touch, a little hard in that area and slightly itchy. I have no other symptoms and feel fine just noticed it when I was getting ready this morning.
Redness and swelling at site and on upper arm. Low grade fever, malaise, shivering and hot clammy.
DEATH; This spontaneous report received from a physician via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, once total, administered on 2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, three days after vaccination, the patient died of unknown cause. It was unknown, whether autopsy was performed or not. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. This report was serious (Death).; Sender's Comments: covid-19 vaccine ad26.cov2.s-Death. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
This spontaneous report as received from a nurse concerning a patient of unknown age and gender. Information regarding the patient's current conditions, medical history or concomitant medications was not reported. On an unknown date, the patient was vaccinated with VARIVAX and/or M-M-R-II (dose, route, lot# and expiration date were not reported).  On an unspecified date, the patient developed hives after receiving either VARIVAX or M-M-R II.  The outcome of the event was not reported. The nurse did not know which product caused the patient to develop hives.  Additional information is not expected as there was no consent to contact the reporter.
hi fever, chills, shaking , headache, fatigue, heavy night sweats-I.E. worse than the covid infection I had
I got injection site redness and it kind of hurt, just kind of pain; I got injection site redness and it kind of hurt, just kind of pain; I am kind of hard of hearing; This is a spontaneous report from a contactable consumer. A 84-years-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number EL1283, via an unspecified route of administration on an unspecified date at SINGLE DOSE for covid-19 immunisation. The patient medical historyand concomitant medications were not reported. The patient experienced "injection site redness and it kind of hurt, just kind of pain but definitely it is red "on an unspecified date with outcome of unknown, and "I am kind of hard of hearing" on an unspecified date with outcome of unknown. The action taken  was not applicable.
numbness soon after vaccine, as the day progressed difficult elevate left arm, resolved by next morning
20 MINUTES AFTER INJECTION CLIENT C/O HEADACHE,  DIZZINESS, SHORTNESS OF BREATH, AND CHEST PAIN.  HE APPEARED PALE.  NO DIAPOHORESIS.  HE STATED THAT HE HAS A HISTORY OF ANXIETY AND DEPRESSION THAT IS NOT CURRENTLY TREATED.  HE WAS PLACED IN A SUPINE POSTION AND STATED THAT HE FELT BETTER AFTER LYING DOWN.  VS WNL 3:30 PM HR 94, RR 20, BP 118/70, 3:40 HR 74, RR 18, BP 110/70.  3;48 HR 70, RR 16, BP 110/68.  4:02 HR 86, RR 16 BP 108/66.  REMAINED WNL.  NO FURTHER CP @ 3:48, NO SOB, SKIN WARM AND DRY.  HYDRATED WITH WATER AND GIVEN A LOLLIPOP.  4:00 ALL SYMPTOMS RESOLVED, VSS THROUGHOUT.  PATIENTS FRIEND DROVE HIM HOME. PATIENT REFUSED/EMERGENCY HELP.  INSTRUCTED TO GO TO ER IF CP OR ANY SX'S RETURN.
Patient had swelling in the lower part of his left arm. He was instructed to contact his MD whom ordered an MRI to rule out a blood clot. The MRI was clear and the patient will see the MD again tomorrow.
Experienced the expected redness, swelling, etc.  About four days later, as swelling was subsiding, the deltoid muscle in the upper arm began to experience severe, prominent pain in motion.  The discomfort was felt all the way to the thumb joing.  Now, five days later, the pain is reduced, but still have a bit of joint pain in the left hand and newly in the left hip.  The vaccination area of the arm continues to "feel different" from the other upper arm.  This is not a serious side effect, but it was remarkable enough that I felt I should report it.
joint pain; knees swelled; headache; nausea; dizziness; fatigue; This is a spontaneous report from a contactable consumer (patient). A 62-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in left arm on 30Mar2021 at 09:30 (age at vaccination was 62-year-old) as dose 2, single for COVID-19 immunization. The patient's medical history included pain in legs (undiagnosed), lyme disease and allergic to most narcotic pain meds. The patient's concomitant medications included baclofen 5 mg, gabapentin 300 mg and eye drops (as reported) for glaucoma; all from an unspecified date. The patient did not receive any other vaccine within 4 weeks prior to COVID-19 vaccine. Prior to vaccination, the patient has not been diagnosed with COVID-19 and since the vaccination, the patient has not been tested for COVID-19.  The patient's historical vaccine included  BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Solution for injection, Lot number was not reported), via an unspecified route of administration, administered in left arm on 09Mar2021 at 09:30 (age at vaccination was 62-year-old) as dose 1, single for COVID-19 immunization and experienced migraine, nausea, hot flashes, leg pain, dizziness, sinus running, chills, and fatigue. On an unspecified date of 2021, the patient experienced joint pain, knees swelled, headache (less severe), nausea, dizziness, and fatigue. It was reported that the events in dose 1 was worse than dose 2. No therapeutic measures were taken as a result of the events. The outcome of the events was recovering.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
REBOUND COVID; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 43 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient previously received covid-19 vaccine ad26.cov2.s (Dose number in series 1) (suspension for injection, intramuscular, batch number: 1805081 and expiry: unknown) dose was not reported, 1 total administered on 13-MAR-2021 at 12:45 on left arm for prophylactic vaccination. Age at time of vaccination 42 years old. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26. cov2.s (Dose number in series 1). No concomitant medications were reported. The patient received second dose of covid-19 vaccine (unspecified manufacturer) (Dose number in series 2) (form of admin, route of admin was not reported, batch number: unknown expiry: unknown) dose was not reported, administered on unspecified date for prophylactic vaccination. It was unknown whether patient had any adverse events following vaccination with second dose of covid-19 vaccine (unspecified manufacturer) (Dose number in series 2). The patient received third dose of non-company suspect vaccine included: Moderna covid-19 vaccine (Spikevax) (Dose number in series 2) (form of admin, route of admin was not reported, batch number: 032F21A expiry: unknown) dose was not reported, administered on 30-OCT-2021 at 13:00 in left arm for prophylactic vaccination.  Treatment medications included: Paxlovid (ritonavir/nirmatrelvir) from 25-APR-2022 to 01-MAY-2022 for covid-19. On 07-MAY-2022 at 18:00 the patient experienced rebound covid (Dose number in series 2). The action taken with covid-19 vaccine ad26.cov2.s, covid-19 vaccine (unspecified manufacturer) and Spikevax was not applicable. The patient had not recovered from rebound covid. This report was non-serious.
Tender and sore initially, woke up at 3 AM with swollen shoulder/upper arm at and below injection site, painful and hot. Swelling decreased gradually through the day. By 7 PM just tender at site.
9-16-11 DTaP 0.5ml Sanofi-Pasteur Lot - U4104AA Exp 2/24/2014 administered IM left deltoid NDC 49281-400-15. 9-22-11 - Reported red warm knot on arm, smaller dime. 9-23-11 office visit for local reaction at injection site. Advised cool compresses and LIDEX cream.
hives all over the body; soreness on her left arm; A spontaneous report was received from a non-health professional concerning a female consumer, of unknown age, who received Moderna's COVID-19 vaccine and developed hives and soreness on her left arm.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 26 Dec 2020, prior to the onset of the events, the patient received their first of two doses of mRNA-1273 (Lot number: 026L20A) intramuscularly in the left arm for prophylaxis of COVID-19 infection.     On 26 Dec 2020, after receiving her vaccination, the patient began to develop soreness on her left arm. On 2 Jan 2021, she developed hives all over the body. Treatment for the event included prednisone for her hives.  Action taken with mRNA-1273 in response to the events was not reported.  The outcome for the events, hives and soreness on her left arm, was unknown.   The reporter's assessment of causality for the event was not provided.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.